Unusual cytogenetic evolution in CML treated with interferon-alpha

被引:1
作者
Maloisel, F [1 ]
Laplace, A [1 ]
Uettwiller, F [1 ]
Lioure, B [1 ]
Oberling, F [1 ]
机构
[1] HOP UNIV STRASBOURG,LAB CYTOGENET,F-67098 STRASBOURG,FRANCE
关键词
D O I
10.1038/sj.leu.2400660
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:893 / 894
页数:2
相关论文
共 5 条
[1]   PROLONGED ADMINISTRATION OF INTERFERON-ALPHA IN PATIENTS WITH CHRONIC-PHASE PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA BEFORE ALLOGENEIC BONE-MARROW TRANSPLANTATION MAY ADVERSELY AFFECT TRANSPLANT OUTCOME [J].
BEELEN, DW ;
GRAEVEN, U ;
ELMAAGACLI, AH ;
NIEDERLE, N ;
KLOKE, O ;
OPALKA, B ;
SCHAEFER, UW .
BLOOD, 1995, 85 (10) :2981-2990
[2]  
GUILHOT F, 1996, BONE MARROW TRANS S3, V17, P29
[3]  
Johansson B, 1996, LEUKEMIA, V10, P1134
[4]  
PESCHEL C, 1993, SEMIN HEMATOL, V30, P28
[5]   IMMUNE-MEDIATED AND UNUSUAL COMPLICATIONS DURING INTERFERON-ALFA THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA [J].
SACCHI, S ;
KANTARJIAN, H ;
OBRIEN, S ;
COHEN, PR ;
PIERCE, S ;
TALPAZ, M .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) :2401-2407